This inventor holds 4 USPTO granted patents. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1976-1979.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nagaokakyo, JA (1976 - 1978)
- Nagaokakyo, JP (1979)
Company Filing History:
Years Active: 1976-1979
Title: Noriaki Shimokawa: Innovator in Pharmaceutical Chemistry
Introduction
Noriaki Shimokawa is a prominent inventor based in Nagaokakyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of piperazine derivatives. With a total of 4 patents to his name, his work has implications for analgesic and antitussive compositions.
Latest Patents
Shimokawa's latest patents include innovative 1-Substituted-4-(1,2-diphenylethyl)piperazine derivatives. These derivatives are characterized by specific chemical formulas where X can be 2- or 3-hydroxy, 2-methoxy, 3-methyl, or 3-alkoxy with varying carbon chain lengths. The R group in these compounds can include various substituents such as allyl, cyclohexyl, or phenyl groups. These compounds are not only novel but also have potential applications in pharmaceutical formulations.
Career Highlights
Noriaki Shimokawa is associated with Dainippon Pharmaceutical Company, Limited, where he has been instrumental in advancing research and development in pharmaceutical products. His expertise in synthesizing complex chemical compounds has positioned him as a key figure in his field.
Collaborations
Throughout his career, Shimokawa has collaborated with notable colleagues such as Haruki Nishimura and Hitoshi Uno. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical compounds.
Conclusion
Noriaki Shimokawa's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the industry. His work continues to influence the development of effective medicinal compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
